Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 107526
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.107526
Table 5 Univariate regression analysis
Factor
n
3-year overall survival (%)
95%CI
χ²
P value
Gender0.0770.898
Male15134.4527.31-38.92
Female14942.2727.12-41.13
Age0.3270.7420.393
≤ 60 years16239.8729.51-41.77
> 60 years13831.6524.31-37.65
American Society of Anesthesiologists grade0.0430.992
15647.9222.17-44.91
221334.6328.21-38.94
33125.1818.81-41.56
Intraoperative contrast-enhanced ultrasound with Sonazoid0.7980.000
Yes15054.8719.46-41.17
No15033.2728.32-37.91
Postoperative T stage0.4630.521
T2-T322943.3129.69-40.28
T47121.2421.36-38.77
Postoperative N stage7.9540.020
N011454.3133.22-47.51
N111826.4225.47-39.69
N26826.3814.78-32.91
Number of liver mets5.2690.033
≤ 318249.1231.92-44.93
>311824.6322.31-34.17
Tumor differentiation6.1990.024
Low14252.3733.12-45.64
Moderate/high15822.6521.42-33.57